Abstract
BACKGROUND: Neutrophil-to-lymphocyte ratio (NLR) has been presented as a possible indicator associated with the outcomes of growing patients and an available predictor of inflammation. Nevertheless, just a handful of researches shed light on the association between NLR and the consequences of critical patients with coronary artery disease (CAD). The study aimed to investigate the correlation between NLR and all-cause mortality of short-term and long-term in patients with CAD. METHODS: We obtained objective data from the Medical Information Mart for Intensive Care (MIMIC)-IV version 2.2, a comprehensive and large-scale single-center database. NLR was calculated separately. Patients were categorized by quartiles of NLR: Q1 group (NLR < 3.56), Q2 (NLR 3.56-5.54), Q3 group (NLR 5.54-9.05), Q4 group (NLR > 9.05). Kaplan-Meier survival curves based on NLR quartiles were created to compare all-cause mortality rates, and the log-rank test evaluated the differences between groups. The hazard ratio (HR) of NLR as a risk factor for outcome events was assessed using the Cox proportional risk model with the Q1 group serving as the reference group and restricted cubic spline (RCS) with the infection points of 5.54. RESULTS: A total of 3,692 patients were included in this study. The 30-day mortality rate among the patients was 8.85%, while the 365-day mortality rate was 16.98%. High NLR (NLR > 5.54) was significantly associated with 30-day mortality [HR, 3.99,95% confident interval (CI), (3.03-5.24); P < 0.001] and 365-day mortality [HR, 5.72, 95% CI (3.83-8.54); P < 0.001] in patients with critical CAD in the completely adjusted Cox proportional risk model. RCS analysis revealed a U-shaped relationship between NLR and outcome events. CONCLUSION: In patients diagnosed with critical CAD, a significant correlation was observed between NLR and all-cause mortality, particularly among individuals exhibiting elevated NLR levels. These findings suggest that NLR may serve as a valuable prognostic marker for evaluating both short-term and long-term mortality risk in this patient population.